Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Observational 1

Sponsor

Conditions

Multiple Myeloma 2Depression 2Breast Neoplasms 2Anxiety Disorders 2Uveal Melanoma 1Small Cell Lung Carcinoma 1Prolactin-Producing Pituitary Tumor 1Pituitary ACTH Hypersecretion 1Neoplasms 1Neoplasm Metastasis 1Metastatic Solid Tumor Cancers 1Lung Neoplasms 1Glioma 1Glioblastoma 1Cushing Syndrome 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Cancer Caregivers 1

Interventions

pembrolizumab 185Gemcitabine 170Paclitaxel 152Carboplatin 137Bevacizumab 128Surveys and Questionnaires 118Cisplatin 115Docetaxel 114Blood Specimen Collection 110Cyclophosphamide 109Exercise 108Nivolumab 99Fluorouracil 90Capecitabine 86Radiotherapy 81Dexamethasone 81Irinotecan 74Standard of Care 69Pemetrexed 68Oxaliplatin 68Drug Therapy 65Leucovorin 64Cetuximab 60Erlotinib Hydrochloride 56atezolizumab 53Sorafenib 53Ipilimumab 51Doxorubicin 50trametinib 47Interviews as Topic 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × 4-amino-4'-hydroxylaminodiphenylsulfone × Clear all
NCT05596344 2023-11-13

Long-term Follow-up of Anxiety and Depression in Patients With Malignant Tumors

Henan Cancer Hospital

Recruiting
200 enrolled

Anxiety Disorders, Depression, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡